Updates in Pharmacology O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone TreatmentDownload O-1602-an-Agonist-of-Atypical-Cannabinoid-Receptors-GPR55-Reverses-the-Symptoms-of-Depression-and-Detrusor-Overactivity-in-Rats-Subjected-to-Corticosterone-Treatment Share: Newer Post The Call for Sustainable and Resilient Policies in the COVID-19 Crisis: How Can They Be Interpreted and Implemented? Older Post High-Frequency Power of Heart Rate Variability can predict the Outcome of Thoracic Surgical Patients with Acute Respiratory Distress Syndrome on Admission to the Intensive Care Unit: A Prospective, Single-Centric, Case-Controlled Study